Two-Dimensional 3 Tesla MRS of the Brain in HIV- Infected Youth
HIV 感染青少年大脑的二维 3 Tesla MRS
基本信息
- 批准号:7494784
- 负责人:
- 金额:$ 17.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAffectAgeAlgorithmsAmino AcidsAminobutyric AcidAminobutyric AcidsAnti-Retroviral AgentsAntioxidantsApplications GrantsAreaAttentionBasal GangliaBrainBrain regionCD4 Lymphocyte CountCD4 Positive T LymphocytesCerebrumChildCholineChronicChronic DiseaseClinicalCognitiveCreatineCrowdingCysteineDataDegenerative DisorderDementiaDetectionDevelopmentDimensionsDrug Metabolic DetoxicationEarly treatmentElevationEncephalitisEvaluationFutureGenderGliosisGlutamatesGlutamineGlutathioneGlycineGoalsGuidelinesHIVHIV InfectionsHealthHighly Active Antiretroviral TherapyImpaired cognitionIndividualInflammationInositolInvestigationLeftLongitudinal StudiesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMembraneMetabolicMothersMotorMotor ActivityN-acetylaspartateNervous System TraumaNeuraxisNeurogliaNeurologicNeuronsNeuropsychological TestsNeurotransmittersNoiseOxidative StressParkinson DiseasePathologyPatientsPenetrationPerformancePharmaceutical PreparationsPhosphorylcholinePlasmaPublic HealthQuality of lifeReactionReportingResearch PersonnelScoreSignal TransductionSpectrum AnalysisSystemTechniquesTestingTimeViral Load resultYouthage relatedantiretroviral therapybasecognitive functioncohortcomputerizedcritical developmental periodexecutive functiongamma-Aminobutyric Acidimprovedinterestmotor impairmentmyelinationneurocognitive testperformance testsphosphoethanolaminetooltransmission processtwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): HIV in adults and children has become a chronic illness and there is a critical need to develop noninvasive, reliable techniques to detect sub clinical involvement of the brain by HIV. Magnetic resonance spectroscopy (MRS) permits the study of HIV effects on cerebral metabolites, markers of neuronal and glial cell health. Most previous investigations have used 1.5 Tesla (T) scanners and one-dimensional MRS (1D-MRS) techniques. The primary goal of this study is to use an improved technique, a two-dimensional MRS technique (2D-MRS) on a 3 T scanner, to detect abnormal cerebral metabolites in HIV-infected patients, and to correlate abnormal cerebral metabolites with performance on neurocognitive tests, in order to better assess brain development and function in these individuals. A 3T scanner is expected to offer improved signal to noise ratios (SNR) and lower coefficients of variance compared to 1.5 T. The use of 2D-MRS allows the detection of many additional metabolites compared to traditional 1D-MRS by converting a crowded, overlapping 1D-MRS spectrum to a better resolved 2D spectrum through the addition of a spectral dimension. Of particular interest are GABA, an inhibitory neurotransmitter and myo-inositol (mI), a glial cell marker for which elevation suggests ongoing inflammation. Metabolite ratios to reference metabolites and metabolite concentrations will be determined. The 3 Tesla scanner combined with 2D-MRS also provides the ability to study glutathione (GSH), an important cellular antioxidant protector molecule that could assess central nervous system damage by the HIV virus. The specific aims of this study are to compare GABA, mI, choline groups, GSH and other metabolites in the right frontal brain region and right basal ganglia of 30 HIV-infected patients and 30 control subjects. Both of these areas of the brain have been documented to be involved in the central nervous system pathology of HIV. The hypotheses are that GABA and mI will be increased in HIV-infected patients while GSH will be decreased and that the changes in concentrations of these metabolites will correlate with poorer performance on neurocognitive tests of executive functioning, fine motor activity, and attention. In addition to the better assessment of brain development and function, reliable identification of perinatally HIV-infected youths with abnormal cerebral metabolites and sub clinical brain involvement by 2D-MRS (3T) may also direct earlier therapy than the current CD4 count criteria would indicate or changing existing HAART therapy to antiretroviral medications with improved CNS penetration. This study could potentially improve the quality of life of HIV-infected youths and preserve the health of the central nervous system. PUBLIC HEALTH RELEVANCE This study plans to identify metabolite markers of HIV involvement of the brain using noninvasive magnetic resonance spectroscopy in perinatally HIV-infected youths. Cerebral metabolite levels will be correlated with performance on neuropsychological tests and will identify involvement of the brain before clinical detection. Such results could dictate earlier therapy in children and youths with high CD4 cells or a change in antiretroviral medication to better treat HIV infection of the brain and improve the quality of life and neurological health of the millions of children worldwide infected with HIV from the mother.
描述(由申请人提供):成人和儿童的艾滋病毒已成为一种慢性疾病,并且需要开发无创,可靠的技术来检测艾滋病毒对大脑的临床临床参与。磁共振光谱(MRS)允许研究HIV对脑代谢产物,神经元和神经胶质细胞健康的影响。以前的大多数研究都使用了1.5台扫描仪和一维MRS(1D-MRS)技术。这项研究的主要目的是使用改进的技术,即3 T扫描仪上的二维MRS技术(2D-MRS),以检测HIV感染患者的脑脑代谢异常,并将脑异常代谢物与神经认知测试的表现相关,以更好地评估这些个体,以改善这些个体,以评估这些个体的大脑开发和功能。与1.5 t相比,预计3T扫描仪将提供提高信号与噪声比(SNR)和较低的差异系数。与传统的1d-MR相比,使用2D-MR可以通过将较拥挤的,重叠的,重叠的1D-MR频谱转换为通过更好地溶解的2D 2D光谱的频谱来检测许多其他代谢物。特别令人感兴趣的是GABA,GABA是一种抑制性神经递质和肌醇(MI),这是一种神经胶质细胞标记,升高表明持续的炎症。将确定代谢物与参考代谢物和代谢产物浓度的比率。 3种特斯拉扫描仪与2D-MR相结合还提供了研究谷胱甘肽(GSH)的能力,谷胱甘肽(GSH)是一种重要的细胞抗氧化剂保护剂分子,可以评估HIV病毒中枢神经系统损害。这项研究的具体目的是比较右额脑区域中的GABA,MI,GSH,GSH和其他代谢产物,以及30名HIV感染患者的右基底神经节和30名对照组。大脑的这两个区域均已证明与艾滋病毒的中枢神经系统病理有关。假设是HIV感染患者的GABA和MI将增加,而GSH将减少,并且这些代谢产物浓度的变化将与执行功能,良好运动活动和注意力的神经认知测试的性能较差相关。除了更好地评估大脑发育和功能外,对脑部HIV感染的年轻人的可靠鉴定,具有异常的脑代谢物和2D-MRS(3T)的临床脑部受累也可能与当前的CD4计数标准相比,还可能指出与现有的HAART治疗相比,与当前的CD4计数标准相比,对现有的HAART疗法对抗逆转录病毒的治疗进行了改善。这项研究可能会改善感染HIV的年轻人的生活质量,并保留中枢神经系统的健康。公共卫生相关性本研究计划使用非侵入性磁共振光谱在围产期感染HIV感染的年轻人中使用非侵入性磁共振光谱来鉴定大脑的艾滋病毒参与。脑代谢物水平将与神经心理学测试的性能相关,并在临床检测前确定大脑的参与。这样的结果可能决定了患有高CD4细胞的儿童和青少年的早期治疗,或者抗逆转录病毒药物的变化可以更好地治疗大脑的HIV感染,并改善全世界全世界感染HIV感染HIV的儿童的生活质量和神经健康健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET A KELLER其他文献
MARGARET A KELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET A KELLER', 18)}}的其他基金
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS HIV
抗逆转录病毒药物组合 HIV 的深入药代动力学研究
- 批准号:
8174501 - 财政年份:2009
- 资助金额:
$ 17.52万 - 项目类别:
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS
抗逆转录病毒药物组合的深入药代动力学研究
- 批准号:
7952269 - 财政年份:2008
- 资助金额:
$ 17.52万 - 项目类别:
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY
妊娠期间抗逆转录病毒治疗的药代动力学特性
- 批准号:
7606170 - 财政年份:2007
- 资助金额:
$ 17.52万 - 项目类别:
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN VERTICALLY HIV-INFEC
垂直 HIV 感染者形态和代谢异常的患病率
- 批准号:
7376075 - 财政年份:2005
- 资助金额:
$ 17.52万 - 项目类别:
MONTHER-INFANT RAPID INTERVENTION AT DELIVERY (MIRIAD)
分娩时的月婴快速干预 (MIRIAD)
- 批准号:
7206392 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN HIV-INFECTED CHILDREN
抗逆转录病毒治疗对艾滋病毒感染儿童身体成分的影响
- 批准号:
7206388 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
RANDOMIZED TRIAL OF PROTEASE INHIBITOR-INCLUDING VS. PRO
含蛋白酶抑制剂与含蛋白酶抑制剂的随机试验
- 批准号:
7042126 - 财政年份:2003
- 资助金额:
$ 17.52万 - 项目类别:
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN HIV-INFECTED CHILDREN
抗逆转录病毒治疗对艾滋病毒感染儿童身体成分的影响
- 批准号:
7042137 - 财政年份:2003
- 资助金额:
$ 17.52万 - 项目类别:
ACTG382 PHARMACOKINETICS, SAFETY, TOLERABILITY&ANTIVIRAL ACTIVITY OF
ACTG382 药代动力学、安全性、耐受性
- 批准号:
6416298 - 财政年份:2000
- 资助金额:
$ 17.52万 - 项目类别:
ACTG300 COMBINED ZIDOVUDINE LAMIVUDINE VS BETTER OF DDI MONOTHERAPY V
ACTG300 联合齐多夫定 拉米夫定 VS 更好的 DDI 单疗法 V
- 批准号:
6416325 - 财政年份:2000
- 资助金额:
$ 17.52万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
- 批准号:
10751263 - 财政年份:2024
- 资助金额:
$ 17.52万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Is gestational sleep apnea a previously unrecognized cause of maternal immune activation that predisposes male offspring to disease-relevant neural dysfunction?
妊娠期睡眠呼吸暂停是否是一种以前未被认识到的母体免疫激活的原因,导致男性后代容易出现与疾病相关的神经功能障碍?
- 批准号:
10680972 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Imaging transcriptomics across developmental stages of early psychotic illness
早期精神病发展阶段的转录组学成像
- 批准号:
10664783 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别:
Expanding minority youth access to evidence-based care: A pilot effectiveness trial of a digital mental health intervention
扩大少数族裔青年获得循证护理的机会:数字心理健康干预措施的试点有效性试验
- 批准号:
10647287 - 财政年份:2023
- 资助金额:
$ 17.52万 - 项目类别: